Asia-Pacific stocks set for mixed start; optimism rises on Pfizer vaccine approval

  • 📰 CNBC
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 72%

Canada News News

Canada Canada Latest News,Canada Canada Headlines

Pfizer and BioNTech's Covid-19 vaccine became the first in the U.S. on Monday to be granted full approval by the Food and Drug Administration.

Reuters reported that the U.S. Securities and Exchange Commission has began issuing new disclosure requirements to Chinese firms looking to list in New York.

SINGAPORE — Shares in Asia-Pacific looked set for a mixed start on Tuesday, after the tech-heavy Nasdaq Composite rose to a record closing high following theFutures pointed to a higher open in Japan. The Nikkei futures contract in Chicago was at 27,660 while its counterpart in Osaka was at 27,620. That compared against theAustralian stocks, on the other hand, looked poised for an opening slip.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Eyes on dua listed $BABA $JB $BIDU

good luck

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in CA

Canada Canada Latest News, Canada Canada Headlines